Operating Profit Margin
since 2013
Calculation
IQVIA Holdings Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income from operations1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 12.48% | = | 100 | × | 1,799) | ÷ | 14,410) |
| Dec 31, 2021 | 10.04% | = | 100 | × | 1,393) | ÷ | 13,874) |
| Dec 31, 2020 | 6.44% | = | 100 | × | 731) | ÷ | 11,359) |
| Dec 31, 2019 | 7.01% | = | 100 | × | 777) | ÷ | 11,088) |
| Dec 31, 2018 | 7.12% | = | 100 | × | 741) | ÷ | 10,412) |
| Dec 31, 2017 | 7.38% | = | 100 | × | 719) | ÷ | 9,739) |
| Dec 31, 2016 | 9.33% | = | 100 | × | 642) | ÷ | 6,878) |
| Dec 31, 2015 | 11.27% | = | 100 | × | 647) | ÷ | 5,738) |
| Dec 31, 2014 | 10.81% | = | 100 | × | 590) | ÷ | 5,460) |
| Dec 31, 2013 | 9.07% | = | 100 | × | 462) | ÷ | 5,100) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 US$ in millions
- Income from operations
- The income from operations demonstrated an overall upward trend from 2013 to 2022, increasing from 462 million US dollars to 1799 million US dollars. There were some fluctuations within this period; for instance, income rose steadily from 462 million in 2013 to 777 million in 2019, followed by a decline to 731 million in 2020. Subsequently, it recovered strongly to reach a peak of 1799 million by the end of 2022. This suggests periods of operational challenges in 2020, possibly related to external factors affecting business, but a significant recovery and growth afterward.
- Revenues
- Revenues exhibited a consistent increase throughout the entire period, growing from 5100 million US dollars in 2013 to 14410 million US dollars in 2022. Notably, revenue growth accelerated sharply between 2016 and 2017, with a rise from 6878 million to 9739 million US dollars, marking a substantial expansion phase. Although growth rates moderated slightly in subsequent years, the overall trend remains strongly positive, indicating continuous expansion of the company's sales base and market reach.
- Operating profit margin
- The operating profit margin showed variability over the years with some notable trends. It increased from 9.07% in 2013 to a peak of 11.27% in 2015, followed by a decline reaching a low of 6.44% in 2020. This decline coincides with the drop in income from operations in 2020 despite rising revenues, implying increased operating costs or margin pressures. After 2020, operating margins improved markedly, reaching 12.48% in 2022, the highest level in the observed period, signaling enhanced operational efficiency or cost management in recent years.
- Overall Insights
- The company experienced strong revenue growth throughout the period analyzed, reflecting successful top-line expansion. Income from operations followed a similar upward trajectory despite short-term setbacks in 2020, perhaps influenced by external market conditions. The operating profit margin trend suggests phases of operational efficiency gains alternating with periods of margin compression. The recovery in operating profit margin and income from operations after 2020 indicates effective strategic adjustments or market recovery. The overall picture is one of robust growth accompanied by fluctuating profitability metrics that improved substantially in the most recent years.
Comparison to Competitors
IQVIA Holdings Inc., operating profit margin, long-term trends, comparison to competitors
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 12.48% | 31.21% | 38.57% | 27.61% | 27.17% | 38.93% | 18.69% | 48.23% |
| Dec 31, 2021 | 10.04% | 31.89% | 31.44% | 25.35% | 36.72% | 55.67% | 25.57% | 36.73% |
| Dec 31, 2020 | 6.44% | 24.81% | 37.70% | 18.99% | 16.72% | 42.09% | 24.19% | 46.03% |
| Dec 31, 2019 | 7.01% | 39.03% | 43.57% | 18.25% | 19.38% | 28.10% | 17.99% | 28.77% |
| Dec 31, 2018 | 7.12% | 19.49% | 45.55% | 17.11% | 37.83% | 37.77% | 15.53% | 20.84% |
| Dec 31, 2017 | 7.38% | 33.99% | 45.76% | 16.48% | 55.04% | 35.41% | 14.19% | 4.95% |
| Dec 31, 2016 | 9.33% | 36.60% | 44.74% | 16.29% | 58.87% | 27.38% | 13.40% | 0.58% |
| Dec 31, 2015 | 11.27% | 32.97% | 40.44% | 16.87% | 69.03% | 30.51% | 13.77% | -45.23% |
| Dec 31, 2014 | 10.81% | 17.09% | 32.03% | 17.23% | 62.37% | 29.74% | 14.82% | -119.30% |
| Dec 31, 2013 | 9.07% | 30.14% | 32.25% | 17.13% | 41.87% | 36.11% | 12.30% | -74.54% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).